Article
Improvement of glucose and lipid metabolism with pegylated interferon-a plus ribavirin therapy in Chinese patients chronically infected with genotype 1b hepatitis C virus.
Annals of Saudi medicine - 1 Jan 2000
Qing Shao, Ji Dong, Li Bing, Li Fan, Wang Yudong, Niu Xioaxia, Ling Binfang, Meng Yuhua, Lau George, Chen Guofeng
Abstract excerpt
BACKGROUND: Many epidemiological studies have demonstrated a significant association between Type 2 diabetes mellitus and abnormal lipid profiles with chronic HCV genotype 1 (GT1) infection. We examined the impact on glucose and lipid profiles of treating Chinese patients using pegylated interferon (Peg-IFN)-a and ribavirin (RBV). METHODS: We conducted a hospital-based clinical study of Chinese patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.